Monalizumab Biosimilar - Ultra Low Endotoxin
Product Specifications
Background
Product Name Alternative
KLRC1, NKG2A, CD159a, CD94
UniProt
P26715
Reactivity
Human
Target
NKG2A
Isotype
IgG4
Sequence
https://www.imgt.org/mAb-DB/
Applications
Functional Assays
Purification Method
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Concentration
5mg/mL
Endotoxin
≤ 0.1 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Buffer
ICH3002
Shipping Conditions
Blue ice
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Specificity
Detects human CD159a. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Monalizumab.
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Applications Notes
This biosimilar is for research use only (RUO) : it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Isotype Control
Bulk Human IgG4 Isotype Control (IB4) [ICH2257]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
YEATS4 (YEATS4, GAS41, YEATS domain-containing protein 4, Glioma-amplified sequence 41, NuMA-binding protein 1) (MaxLight 550) discontinued
